STABLECOIN DEVELOPMENT CORP
SDEVNYSE AMERICANTrading Snapshot
- Day Range
- $3.22 – $3.32
- 52-Week Range
- $0.78 – $99.75
- Volume
- $1.83B
- Avg Volume
- $1.59B
- Shares Outstanding
- 50.5M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $28M
- Last Q Revenue
- $2M
- P/E Ratio
- 0.2
- P/S Ratio
- 2.7x
- EPS (TTM)
- $-0.43
- Dividend Yield
- —
- Dilution (1yr)
- +495.7%
Why Investors Own SDEV
- ✓High-growth profile — revenue up +53.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 35% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
STABLECOIN DEVELOPMENT CORP
SDEV
StockOtter · stockotter.spaceAbout STABLECOIN DEVELOPMENT CORP
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Stablecoin Development Stock Skyrockets Tuesday: What's Happening?
Shares of Stablecoin Development Corporation (NYSE:SDEV) are surging on heavy trading volume Tuesday afternoon, despite no company-specific news for the session. Here's a closer look at what could be driving the sudden r
Stablecoin Development (NYSEAMERICAN:SDEV) Stock Price Passes Below 200 Day Moving Average – What’s Next?
Stablecoin Development Corporation (NYSEAMERICAN:SDEV - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $1.93 an
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders
Abbott Cooper PLLC is investigating fiduciary duty claims for SDEV (formerly NovaBay Pharmaceuticals) holders who owned shares before August 19, 2025.
Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
Staking revenue of $2.2 million for the quarter and $4.7 million for the first half of 2026 SDEV grew its SKY position to 2.29 billion tokens (approximately 10% of total SKY supply) and eliminated all remaining warrant